198 related articles for article (PubMed ID: 786397)
21. Presence of prelymphoma cells in the bone marrow of the lymphomagenic virus-treated AKR mouse.
Takeuchi H; Kato A; Hays EF
Cancer Res; 1984 Mar; 44(3):1008-11. PubMed ID: 6198077
[TBL] [Abstract][Full Text] [Related]
22. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
Hakim FT; Shearer GM
J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
[TBL] [Abstract][Full Text] [Related]
23. [Suppressive effect of bone marrow cells from normal and leukemic mice on antibody production in culture of spleen cells in vitro].
Sidorovich IG; Pcheliniev SIu; Khalmov RM
Biull Eksp Biol Med; 1980; 89(1):36-8. PubMed ID: 6991020
[TBL] [Abstract][Full Text] [Related]
24. Induction of tolerance to parental marrow grafts in F1 hybrid mice. Evidence for recognition of self-antigens.
Nowicki M; Yankelevich B; Kikly K; Dennert G
J Immunol; 1990 Jan; 144(1):47-52. PubMed ID: 2295797
[TBL] [Abstract][Full Text] [Related]
25. The abrogation of in vivo resistance to parental bone marrow transplantation and of in vitro natural cell-mediated cytotoxicity to the YAC lymphoma by in vivo growth of a transformed thymus-derived cell culture.
Gardner FH; Gallagher MT; Datta SK; Trentin JJ
Exp Hematol; 1980 Sep; 8(8):1040-7. PubMed ID: 7009189
[TBL] [Abstract][Full Text] [Related]
26. [Genetic control of allogenic inhibition of hematopoietic stem cells].
Golovistikov IN; Alekseeva NIu
Genetika; 1975; 11(12):70-7. PubMed ID: 5341
[TBL] [Abstract][Full Text] [Related]
27. [Importance of the time of bone marrow transplantation for demonstration of allogenic inhibition of sten cells].
Golovistikov IN
Biull Eksp Biol Med; 1976 Mar; 81(3):347-8. PubMed ID: 782605
[TBL] [Abstract][Full Text] [Related]
28. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
Dennert G; Anderson CG; Warner J
J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
[TBL] [Abstract][Full Text] [Related]
29. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
Johnson BD; Drobyski WR; Truitt RL
Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
[TBL] [Abstract][Full Text] [Related]
30. AKR murine leukemia viruses and long-term bone marrow cultures from AKR and SJL mice.
Hays EF; Warren J; Hale L; Rodensky D
Exp Hematol; 1980 Jan; 8(1):134-46. PubMed ID: 6250871
[TBL] [Abstract][Full Text] [Related]
31. Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease.
Glass B; Uharek L; Gassmann W; Focks B; Bolouri H; Loeffler H; Mueller-Ruchholtz W
Ann Hematol; 1992 Jun; 64(6):255-9. PubMed ID: 1637877
[TBL] [Abstract][Full Text] [Related]
32. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
[TBL] [Abstract][Full Text] [Related]
33. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. III. Study of the mechanism.
Cibotti R; Churaqui E; Bolonakis-Tsilivakos I; Scott-Algara D; Hallepannenko O; Kosmatopoulos K
J Immunol; 1989 Dec; 143(11):3484-91. PubMed ID: 2573634
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
Cohen P; Vourka-Karussis U; Weiss L; Slavin S
J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
[TBL] [Abstract][Full Text] [Related]
35. Serum immunoglobulin levels in mice. Determination of the low IgA level in AKR mice by an irradiation-resistant factor.
van Muiswinkel WB; de Laat AM; Mink JG; van Oudenaren A; Benner R
Int Arch Allergy Appl Immunol; 1979; 60(3):240-8. PubMed ID: 385505
[TBL] [Abstract][Full Text] [Related]
36. The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro.
Kung SK; Miller RG
J Immunol; 1995 Feb; 154(4):1624-33. PubMed ID: 7836747
[TBL] [Abstract][Full Text] [Related]
37. Genetic resistance to transplantation of xenogeneic bone marrow in mice of various strains: influence of an interferon inducer and age.
Miller SC
Scand J Immunol; 1981 Nov; 14(5):515-22. PubMed ID: 7038854
[TBL] [Abstract][Full Text] [Related]
38. Effect of hemic cells on hybrid resistance.
Lemeneva LN; Chertkov JL
Exp Hematol; 1976 Jul; 4(4):209-20. PubMed ID: 782895
[TBL] [Abstract][Full Text] [Related]
39. Fetal liver cell transplantation in various murine models.
Sanhadji K; Touraine JL; Aitouche A; Vicari A; Chargui J; Goillot E
Bone Marrow Transplant; 1992; 9 Suppl 1():77-82. PubMed ID: 1504674
[TBL] [Abstract][Full Text] [Related]
40. Examinations concerning the development of lymphoma following transplantation i.p. of AKR mouse lymphoma cells into hybrid mice.
Selypes A; Berencsi G
Arch Geschwulstforsch; 1985; 55(2):111-6. PubMed ID: 3859254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
